StockGuru Blog: Dragon International And the Burgeoning Herbal Medicinal Industry
DRGG – Dragon International Group Corp. Stock Guru Profile DRGG Equity Stock Analysis Report on Dragon International A look at the Equity Stock Analysis Report on DRGG Stock Guru continues its review of DRGG’s letter of intent to acquire Hainan Jinguang Pharmaceutical Company, Limited (”Jinguang”), a distributor and manufacturer of Chinese herb medicines. Jinguang’s focus is traditional Chinese Li medicine, one of the major traditional Chinese medicinal herbs. Jinguang has developed its own research and development center under GLP standards, a planting farm under GAP standards, manufacturing facilities under GMP standards, and a dedicated salesforce under GSP standards. It is…